BGB-3111-302

Active, not recruiting

A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström’s Macroglobulinemia (WM)

Beigene Study ID info

BGB-3111-302

ClinicalTrials.gov ID info

EudraCT Number info

2016-002980-33

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents